These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25895140)

  • 1. Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.
    Bradley-Whitman MA; Lovell MA
    Arch Toxicol; 2015 Jul; 89(7):1035-44. PubMed ID: 25895140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease.
    García-Blanco A; Baquero M; Vento M; Gil E; Bataller L; Cháfer-Pericás C
    J Neurol Sci; 2017 Feb; 373():295-302. PubMed ID: 28131209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.
    Olsson B; Hertze J; Lautner R; Zetterberg H; Nägga K; Höglund K; Basun H; Annas P; Lannfelt L; Andreasen N; Minthon L; Blennow K; Hansson O
    J Alzheimers Dis; 2013; 33(1):45-53. PubMed ID: 22890100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
    Mandal PK; Saharan S; Tripathi M; Murari G
    Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective cognitive decline: preclinical manifestation of Alzheimer's disease.
    Lin Y; Shan PY; Jiang WJ; Sheng C; Ma L
    Neurol Sci; 2019 Jan; 40(1):41-49. PubMed ID: 30397816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Defining and disease-modifying therapy for the preclinical stages of Alzheimer's disease].
    Sakurai H; Hanyu H
    Nihon Rinsho; 2016 Mar; 74(3):438-41. PubMed ID: 27025083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective.
    Lewczuk P; Mroczko B; Fagan A; Kornhuber J
    Adv Med Sci; 2015 Mar; 60(1):76-82. PubMed ID: 25579841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New clinical criteria for the Alzheimer's disease spectrum.
    Petersen RC
    Minn Med; 2012 Jan; 95(1):42-5. PubMed ID: 22355912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients.
    Di Domenico F; Pupo G; Giraldo E; Badìa MC; Monllor P; Lloret A; Schininà ME; Giorgi A; Cini C; Tramutola A; Butterfield DA; Viña J; Perluigi M
    Free Radic Biol Med; 2016 Feb; 91():1-9. PubMed ID: 26675344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers.
    Peña-Bautista C; Baquero M; Vento M; Cháfer-Pericás C
    Clin Chim Acta; 2019 Apr; 491():85-90. PubMed ID: 30685358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers.
    Ivanoiu A; Dricot L; Gilis N; Grandin C; Lhommel R; Quenon L; Hanseeuw B
    J Alzheimers Dis; 2015; 43(3):835-47. PubMed ID: 25114071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired visual recognition memory predicts Alzheimer's disease in amnestic mild cognitive impairment.
    Didic M; Felician O; Barbeau EJ; Mancini J; Latger-Florence C; Tramoni E; Ceccaldi M
    Dement Geriatr Cogn Disord; 2013; 35(5-6):291-9. PubMed ID: 23572062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid.
    Monge Argilés JA; Blanco Cantó MA; Leiva Salinas C; Flors L; Muñoz Ruiz C; Sánchez Payá J; Gasparini Berenguer R; Leiva Santana C
    Neurologia; 2014 Sep; 29(7):397-401. PubMed ID: 23969296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.
    Vos S; van Rossum I; Burns L; Knol D; Scheltens P; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Handels R; L'Italien G; van der Flier W; Aalten P; Teunissen C; Barkhof F; Blennow K; Wolz R; Rueckert D; Verhey F; Visser PJ
    Neurobiol Aging; 2012 Oct; 33(10):2272-81. PubMed ID: 22264648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2013; 33 Suppl 1():S243-51. PubMed ID: 22683528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.